Table 1.
Surveillance strategy with systematic high-quality AF-screening
| Study | Size | AF-screening | Device (n) | AF < 1 m | AF ≥ 1 m |
|---|---|---|---|---|---|
| Burow et al. (2008) [19] | 110 | ELR 3 and 6 m | Amplatzer PFO (40) | nd | 6 (15%) |
| Bonvini et al. (2010) [7] | 143 | Holter/ELR 0, 6 and 12 m | Most suitable (92) | 6 (6,5%) | 3 (3,3%) |
| Ates et al. (2015) [23] | 47 | Holter 0, 6 m | Amplatzer PFO (34), Occlutech Figulla (13) | 2 (4,2%) | 0 |
| Leclercq et al. (2021) [11] | 62 | Holter 0, 1, 6 m | Amplatzer PFO (42), Amplatzer Cribiform (15), Occlutech PFO (5) | 3 (4,8%) | 0 |
AF atrial fibrillation, ELR external loop recorder, m month, nd not done